|
|
||||||||
From the Departments of Pathology and Laboratory Medicine (Neuropathology) (Drs. Powers, Herrmann, and Byrne), Neurology (Drs. Henry and Herrmann), Radiology (Drs. Abdelhalim and Shrier), and Medicine (Vascular Medicine) (Dr. Francis), University of Rochester School of Medicine and Dentistry, NY.
Address correspondence and reprint requests to Dr. James M. Powers, University of Rochester Medical Center, Department of Pathology and Laboratory Medicine, 601 Elmwood Avenue, Rochester, NY 14642; e-mail: james_powers{at}urmc.rochester.edu
Strokes have been rarely associated with immunoglobulin G (IVIg) therapy. A 70-year-old woman with stable polycythemia vera developed GuillainBarré syndrome and received IVIg, 8 days following which she became comatose due to bilaterally symmetric cerebral infarcts. Autopsy showed intravascular aggregates of fibrin-IgG but also platelets and a necrotizing microangiopathy in the infarcts.
This article has been cited by other articles:
![]() |
S. Jarius, P. Eichhorn, M. H. Albert, S. Wagenpfeil, M. Wick, B. H. Belohradsky, R. Hohlfeld, D. E. Jenne, and R. Voltz Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNF{alpha}-dependent and Fc-receptor-independent way Blood, May 15, 2007; 109(10): 4376 - 4382. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |